Marine Drugs (Nov 2020)

Interaction of <i>Thalassia testudinum</i> Metabolites with Cytochrome P450 Enzymes and Its Effects on Benzo(a)pyrene-Induced Mutagenicity

  • Livan Delgado-Roche,
  • Rebeca Santes-Palacios,
  • José A. Herrera,
  • Sandra L. Hernández,
  • Mario Riera,
  • Miguel D. Fernández,
  • Fernando Mesta,
  • Gabino Garrido,
  • Idania Rodeiro,
  • Jesús Javier Espinosa-Aguirre

DOI
https://doi.org/10.3390/md18110566
Journal volume & issue
Vol. 18, no. 11
p. 566

Abstract

Read online

The aim of the present work was to evaluate the effects of Thalassia testudinum hydroethanolic extract, its polyphenolic fraction and thalassiolin B on the activity of phase I metabolizing enzymes as well as their antimutagenic effects. Spectrofluorometric techniques were used to evaluate the effect of tested products on rat and human CYP1A and CYP2B activity. The antimutagenic effect of tested products was evaluated in benzo[a]pyrene (BP)-induced mutagenicity assay by an Ames test. Finally, the antimutagenic effect of Thalassia testudinum (100 mg/kg) was assessed in BP-induced mutagenesis in mice. The tested products significantly (p p Thalassia testudinum (100 mg/kg) significantly reduced (p Thalassia testudinum metabolites exhibit antigenotoxic activity mediated, at least, by the inhibition of CYP1A1-mediated BP biotransformation, arresting the oxidative and mutagenic damage. Thus, the metabolites of T. testudinum may represent a potential source of chemopreventive compounds for the adjuvant therapy of cancer.

Keywords